<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02447159</url>
  </required_header>
  <id_info>
    <org_study_id>CCT for PMTCT</org_study_id>
    <nct_id>NCT02447159</nct_id>
  </id_info>
  <brief_title>Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria</brief_title>
  <official_title>Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New Incentives</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial will be conducted to assess the effectiveness of conditional
      cash transfers (CCTs) at increasing retention in prevention of mother-to-child transmission
      (PMTCT) services specifically, in relation to pickup of ARV drugs for infected mothers,
      delivery in the hospital setting, and receipt of drugs for exposed infants. Administrative
      data will be extracted from the All Babies are Equal program and hospital records. At 8-10
      weeks after delivery, an endline survey will also be conducted with each participant to
      provide a deeper understanding of the impact of the CCTs and to assess the reasons for
      retention in PMTCT services.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Nigeria, home to only 2% of the world's population, accounts for 30% of the world's
      mother-to-child transmissions of HIV. Over the past three years, and in collaboration with
      bilateral aid agencies, the Nigerian government has strengthened hundreds of free rural
      clinics, trained thousands of birth attendants, and begun free distribution of antiretroviral
      (ARV) drugs. Despite this, only 1.8% of low-income women deliver a baby with a skilled birth
      attendant, only 16% of HIV-positive pregnant women receive ARVs to prevent mother-to-child
      transmission (PMTCT) of HIV, and only 2.3% of infants born to HIV-infected women received ARV
      prophylaxis to reduce the risk of virus transmission. Pregnant women are lost at each step
      along the PMTCT cascade, from attending a prenatal visit to giving life-saving antiretroviral
      therapy to their newborns.

      Operated by New Incentives, a non-profit organization focused on maternal and child health,
      the All Babies are Equal (ABAE) program was established in June 2014 in Akwa Ibom to improve
      utilization of health services for PMTCT. The ABAE program provides conditional cash
      transfers (CCTs) to pregnant, HIV-positive women conditional on obtaining specific ante-,
      peri-, and postnatal services at public facilities to prevent mother-to-child transmission of
      HIV. The CCT is primarily a demand-side intervention that aims to reduce the barriers that
      women may face when seeking care, as well as encourage uptake of and retention in PMTCT
      services.

      Preliminary studies:

      A large body of evidence indicates that providing ARV drugs to HIV-positive pregnant women
      during pregnancy and at the time of birth to both mother and baby can drastically reduce the
      transmission of the virus to the newborn. However, in Nigeria, even though drugs for PMTCT
      are free and available, many women do not use them. Additionally, knowledge of
      mother-to-child transmission of HIV and PMTCT is high among the investigators' target
      population. Recent research shows that 91% of women of reproductive age have high awareness
      of PMTCT in southern Nigeria, yet 71% have poor attitudes towards PMTCT treatment and
      services, resulting in low uptake of services.

      To encourage uptake of PMTCT services, the ABAE's CCT program was designed based on research
      that has shown that CCT interventions have increased utilization of health services and
      improve child health. CCTs initially used in Latin America provided predictable sums of money
      to eligible mothers when certain actions were taken, particularly for health services and
      school enrollment. The cash payouts have been shown to alleviate short- and long-term poverty
      while building human capital among traditionally underserved populations (i.e. women and
      children in impoverished households). CCTs have also been effective for HIV prevention. For
      example, in Malawi, schoolgirls (aged 13 to 22) awarded between one and five dollars for
      attending school had significantly reduced prevalence of HIV and HSV-2 infection after 18
      months. Additionally, several studies have shown that CCTs are an effective way to improve
      both access and adherence to antiretroviral therapy and to reduce barriers to maternal and
      newborn health service utilization. A CCT program targeted at increasing births in health
      facilities in India found a significant increase in uptake of antenatal and intrapartum care
      services and an increase in facility-based deliveries. As studies continue to evaluate the
      efficacy of CCTs, ongoing efforts aim to determine the impact of these interventions on
      transmission of HIV.

      This study aims to formally evaluate the ABAE program for increasing retention of
      HIV-positive pregnant women in PMTCT through a randomized control trial. Through a
      combination of data extracted from the New Incentives program, facility records, and survey
      data, the researchers will also investigate the sources of poor attitudes towards PMTCT
      services, the influence of non-financial barriers on PMTCT retention, religious and cultural
      norms surrounding delivery outside of clinic settings, and how the CCT intervention should be
      structured to address the full cascade of PMTCT behaviors without compromising operational
      feasibility.

      Main hypothesis to be tested:

      Conditional cash transfers (CCTs) provided by the All Babies Are Equal (ABAE) program carried
      out by New Incentives, a non-governmental organization (NGO), will improve retention of
      HIV-positive, pregnant women in prevention of mother-to-child transmission (PMTCT) services
      in Akwa Ibom, Nigeria.

      Intervention procedures:

      Participant Screening:

      An ABAE program officer will be stationed at each study site on its respective antenatal
      registration (i.e. &quot;Booking day&quot;) day from 8am to 6pm. On Booking Day, all women who test
      positive for HIV will be recorded on a separate list by the HIV counselor or lab tester on
      duty in the privacy of his/her office. For each 1-3 women listed, the names will be
      transferred to the ABAE officer who will then transcribe the list in the order that they
      appear into a spreadsheet with pre-generated random assignment of women to treatment (i.e.
      offered to enroll ABAE program) and control (i.e. not offered the program) groups.
      Individuals randomized to the treatment arm will then be approached by the ABAE officer to
      screen and verify eligibility in person and against the subject's patient record card.

      In-person visit to obtain informed consent:

        -  Potential subjects that have been randomized to the treatment arm will be directed to a
           room where the ABAE program officer will conduct the enrollment process. The ABAE
           officer will then describe the program to the woman, discuss confidentiality and
           privacy, and see if the woman is interested in participating. ABAE program officers will
           follow a standardized enrollment script per the ABAE's standard operating procedures for
           enrollment (see supplementary materials). The ABAE officers will explain both the ABAE
           program and the accompanying research study, following informed consent procedures, and
           obtain written consent for program and study participation. If the subject agrees to
           participate in the program, the ABAE program officer will follow a standardized intake
           protocol, including survey on background information, to enroll the woman into the
           program. She will also be given an informational brochure describing the program,
           including requirements to earn the cash rewards. This brochure is written in a simple
           language and includes visual graphics to facilitate easy understanding.

        -  Women receive a small cash payment and mobile phone credits when she completes
           enrollment to facilitate retrieval of cash from the bank and return phone call
           verification.

      Conditional Cash Transfer 1:

      - The participant enrolled in the ABAE program will call the New Incentives hotline the
      morning after her ANC clinic visit to receive her payment code. If successful, she will
      receive the first lump sum cash payment.

      Conditional Cash Transfer 2:

        -  A New Incentives staff member will check the data sources containing information about
           medication pickups in the antenatal care ward in the morning of each participating
           clinic's Booking Day to check which participants have met the conditions for the second
           conditional cash transfer.

        -  During enrollment, participants are informed to call the New Incentives hotline the
           Friday after retrieving their medications for the second time to receive the payment
           code for the second lump sum payment.

      Conditional Cash Transfer 3:

        -  A New Incentives staff member will call the participant four to six weeks before her
           expected due date to remind her of the third cash transfer. The participant will also be
           reminded about facility delivery by an automated robot call and several text messages.

        -  A New Incentives staff member will check the Labor Ward Registers in the morning of each
           participating clinic's Booking Day to check if study participants have met the delivery
           condition of the third conditional cash transfer.

        -  During enrollment, participants are informed to call the New Incentives hotline the
           Friday after birth to receive the payment code for the third lump sum payment.

      Conditional Cash Transfer 4:

        -  A New Incentives staff member will call the participant four to five weeks after she
           delivers to remind her of the fourth cash transfer. Furthermore, the participant
           receives a text message regarding the early infant diagnosis test that needs to be taken
           six weeks after delivery.

        -  A New Incentives staff member will check the relevant clinic register in the morning of
           each participating clinic's Booking Day to check which participants have met the
           conditions of the third transfer.

        -  During a hotline call, participants are informed to call the New Incentives hotline the
           Friday after receiving the newborn's early infant diagnosis test to receive the payment
           code for the fourth lump sum payment.

      Evaluation design:

      The effect of the conditional cash transfer program on the primary and secondary outcomes
      will be assessed using a randomized control trial. A total of 550 pregnant women testing
      positive for HIV will be screened for eligibility and randomized to the 2 arms.

      Data collection:

      Prior to obtaining consent, the HIV status of all individuals will be collected (this is
      standard procedure at participating clinics for ANC enrollment). For women in the control
      arm, additional administrative clinic data, including first name, last name, patient number,
      pregnant mother number, date of birth, estimated delivery date, month of pregnancy, and phone
      number will be collected prior to obtaining informed consent to facilitate record tracking
      and later endline phone survey. Personal identifiers, however, will be deleted once data
      collection is complete.

      There are 3 main sources of data collection:

        1. Patient records will be extracted from hospital registers on a weekly basis. Extracted
           records will reflect information collated from different facility registers, including
           Patient Card, Laboratory Investigation Report Form, Adult Pharmacy Worksheet, ARV
           Counselor's worksheet, Daily HIV Test worksheet, Nurses' notebooks, lab testers'
           notebook, Delivery Register, Labor Ward Daily Report Book, Admissions Register, Child
           Follow-up Register, Dried Blood Spot Specimen Transport Form, and the Pediatric Pharmacy
           worksheet.

        2. ABAE program data for women in the treatment arm participating in the conditional cash
           transfer program. These data include the information on program participants obtained
           through the program enrollment survey, interim telephone calls and questionnaires, and
           records of cash transfers.

        3. An endline phone survey will be administered to all women enrolled in the study for
           which a valid phone number has been obtained (8-10 weeks after delivery).

             -  At this point, the New Incentives employee will verify the subject's identification
                (i.e. recently was pregnant and registered for antenatal services at the specific
                participating clinic) and obtain verbal informed consent to participate in the
                endline survey.

             -  This is the only contact that control subjects will have with the study personnel.

             -  All individuals completing the phone survey will receive a small amount mobile
                phone credits as compensation for their time.

             -  The endline survey will ask participants about women's birth history,
                decision-making over place of delivery, perceptions on program participation (if
                enrolled in the ABAE program), a discrete choice experiment to elicit state
                preferences over place of delivery (only for women randomized to the control arm),
                and sociodemographic background.

      Data analysis:

        1. Overall program effect:

           Our basic analysis will be to calculate point estimates (e.g., achievement of each cash
           transfer condition) with reasonable precision (i.e., the margin of error) for program
           participants and non-participants overall and for key sub-categories (e.g., at each
           facility) based on data abstracted from hospital records. We will first calculate
           univariate statistics, such as mean retention for each PMTCT condition and standard
           deviations, for program participants and non-participants, and means and standard
           deviations for key sub-categories. We will then test whether retention percentages are
           different between participants and non-participants with 2-tailed chi-squared tests of
           proportions with significance at Î±=0.05. We can test for independent effects,
           confounding, and interactions in multivariate analysis. Logistic regression analyses
           will be used to test for autocorrelation between subjects enrolled at the same facility,
           and hausman tests will be used to assess the relative fit of facility random and fixed
           effects. Possible sources of confounding include differences in HIV testing procedures
           and collection of patient records across facilities and over time (e.g. due to holidays,
           agricultural seasons). For example, logistic regression predicting the likelihood of
           delivering at the facility where ANC was sought can be used to simultaneously assess the
           independent effect of program participation while controlling for facility site, stage
           of pregnancy when enrolled, and time. Sensitivity analyses will be conducted to account
           for known sources of attrition (e.g. participant requesting to be dis-enrolled) and/or
           potential sources of spillover across study arms (e.g. women in the control group
           reporting that they had heard about the ABAE program).

        2. Assess the differences in program attrition and self-reported attitudes and behaviors
           between control and treatment arms.

           With responses from the phone follow-up survey, which will be affected by unknown
           sources of attrition, the study of self-reported behaviors and perceptions is not
           designed to test one central hypothesis, but will involve exploratory statistical
           testing of differences in self-reported behaviors and perceptions among program
           participants vs. non-participants overall, and by key sub-categories (e.g.
           sociodemographic characteristics, location of residence). Standard multiple linear
           regression analysis will be used to assess individual determinants of outcomes and
           changes in outcomes for continuous outcomes. Logistic regression analysis will be used
           for dichotomous outcomes. For ordered categorical outcomes, count data, or potentially
           censored outcomes, we will first assess whether a binomial, poisson, or negative
           binomial distribution is appropriate by examining each outcome's dispersion. Depending
           on the specification tests in #1 above, additional adjustments of autocorrelation will
           be included. Wealth indices will be constructed using standardized methods following
           Filmer and Pritchett (2005).

        3. Assess the existence of heterogeneous treatment effects. Multivariate regression also
           allows for testing interactions, such as whether program participation retention rates
           are different for different groups of patients (e.g., by stage of pregnancy, facility, a
           newly diagnosed HIV case, age).

        4. Determine women's stated preferences for facility-based deliveries. We will complement
           our primary analysis with a discrete choice experiment (DCE). The DCE is designed to
           solicit respondents' preferences over several key childbirth or delivery
           characteristics. Each DCE question asks respondents to state a preference for
           hypothetical options A or B. First, for each question, we will use comparison of means
           (and Chi-squared tests) and regression analysis (and t-tests) to compare the proportion
           of respondents indicating A to the proportion indicating B. Second, using the same
           statistical tools, we will pool questions with overlapping characteristics and measure
           the change in stated choice associated with a particularly delivery characteristic.

      Enrollment projection:

      Sample sizes were calculated assuming a baseline delivery and drug pickup rate of 50%, which
      produced the largest possible variance. A conservative estimate of the effect of the
      intervention would be from a 50% baseline of delivery rates and drug collection to 70% after
      the intervention. Such results would have 99.9% power if each group consists of 250 people.
      Contrary to these conservative calculations assuming a 50% baseline, the baseline rate of
      delivery is approximately 30% at clinic sites and drug pickup rates are even lower, according
      to the clinic data. We therefore expect the study results to have 100% power. Power
      calculations were carried out using the DS Research online power calculator. An additional
      10% upward adjustment is made to account for possible refusals to participate.

      Study sites:

      General Hospital, Ikot Ekpene, Akwa Ibom State, Nigeria General Hospital, Iquita Oron, Akwa
      Ibom State, Nigeria Immanuel General Hospital, Eket, Akwa Ibom State, Nigeria
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number and percentage of pregnant women who deliver their baby at the facility in which they were first enrolled for antenatal care</measure>
    <time_frame>When the woman delivers her child</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number and percentage of mothers who obtain early infant diagnosis testing 6-8 weeks after giving birth to their child</measure>
    <time_frame>6-8 weeks after the woman delivers her child</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of pregnant women who pick up their antiretroviral treatment drugs at least once between enrolling in antenatal care and giving birth to their baby at the facility where they first enrolled in antenatal care</measure>
    <time_frame>Between enrollment into antenatal care until the woman delivers her child</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of mothers who pick up Nevirapine for their newborn infant at the facility where they first enrolled in antenatal care after giving birth</measure>
    <time_frame>48 hours after the woman delivers her child</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">554</enrollment>
  <condition>HIV</condition>
  <condition>HIV Infections</condition>
  <condition>Pregnancy</condition>
  <condition>Infant, Newborn, Diseases</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant in the intervention arm will receive conditional cash transfers when she: (1) registers pregnancy, (2)picks up her medication in the first two months after her first visit, (3) delivers at the health clinic, and (4) receives early infant diagnosis test for newborn. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Antenatal care utilization data will be extracted from the administrative records. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conditional Cash Transfers</intervention_name>
    <description>Each participant in the intervention arm will receive conditional cash transfers when she: (1) registers pregnancy, (2)picks up her medication in the first two months after her first visit, (3) delivers at the health clinic, and (4) receives early infant diagnosis test for newborn. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV positive

          -  Pregnant

          -  Attended an antenatal care visit at one of three participating clinics.

        Exclusion Criteria:

          -  Not HIV positive

          -  Not pregnant

          -  Not registered for antenatal care at a participating clinic.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jenny Liu, PhD, MPP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Immanuel General Hospital</name>
      <address>
        <city>Eket</city>
        <state>Akwa Ibom</state>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital, Ikot Ekpene</name>
      <address>
        <city>Ikot Ekpene</city>
        <state>Akwa Ibom</state>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital, Iquita Oron</name>
      <address>
        <city>Oron</city>
        <state>Akwa Ibom</state>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <reference>
    <citation>Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.</citation>
    <PMID>20238370</PMID>
  </reference>
  <reference>
    <citation>de Walque D, Dow WH, Nathan R, Abdul R, Abilahi F, Gong E, Isdahl Z, Jamison J, Jullu B, Krishnan S, Majura A, Miguel E, Moncada J, Mtenga S, Mwanyangala MA, Packel L, Schachter J, Shirima K, Medlin CA. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012 Feb 8;2:e000747. doi: 10.1136/bmjopen-2011-000747. Print 2012.</citation>
    <PMID>22318666</PMID>
  </reference>
  <reference>
    <citation>Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012 Oct;16(7):1729-38. Review.</citation>
    <PMID>22760738</PMID>
  </reference>
  <reference>
    <citation>Glassman A, Duran D, Fleisher L, Singer D, Sturke R, Angeles G, Charles J, Emrey B, Gleason J, Mwebsa W, Saldana K, Yarrow K, Koblinsky M. Impact of conditional cash transfers on maternal and newborn health. J Health Popul Nutr. 2013 Dec;31(4 Suppl 2):48-66.</citation>
    <PMID>24992803</PMID>
  </reference>
  <reference>
    <citation>Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012 Apr 7;379(9823):1320-9. doi: 10.1016/S0140-6736(11)61709-1. Epub 2012 Feb 15.</citation>
    <PMID>22341825</PMID>
  </reference>
  <reference>
    <citation>Lim SS, Dandona L, Hoisington JA, James SL, Hogan MC, Gakidou E. India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet. 2010 Jun 5;375(9730):2009-23. doi: 10.1016/S0140-6736(10)60744-1.</citation>
    <PMID>20569841</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2015</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Jenny Liu, PhD, MPP</investigator_full_name>
    <investigator_title>Economist</investigator_title>
  </responsible_party>
  <keyword>Nigeria</keyword>
  <keyword>Developing Countries</keyword>
  <keyword>Hospitals, Maternity/Utilization</keyword>
  <keyword>Hospitals/Economics</keyword>
  <keyword>HIV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

